May 05, 2016
NIDA hosts research track at APA annual meeting
The National Institute on Drug Abuse (NIDA) will present a research track at the 2016 American Psychiatric Association’s (APA’s) Annual Meeting in Atlanta, GA from May 14th through 18th. The NIDA sessions will focus on high priority areas related to substance use – including marijuana, tobacco and the prescription opioid and heroin overdose epidemic.
WHAT: NIDA research track at the 2016 American Psychiatric Association’s Annual Meeting.
WHEN: Saturday, May 14 – Wednesday, May 18, 2016
WHERE: Georgia World Congress Center 285 Andrew Young International Blvd. NW
Atlanta, GA 30313
CONTACT: If you are interested in a pre-interview with a NIDA spokesperson about the research track at APA’s Annual Meeting, please contact the NIDA press office at media@nida.nih.gov or 301-443-6245.
Highlights:
- Lecture by NIDA Director
Dr. Nora D. Volkow will present on the topic of "Opioids and Cannabis: Myths and Misperceptions"
Tuesday, May 17; 9:00 a.m. – 10:30 a.m.
Sidney Marcus Auditorium; Building A, Level 4
Additional NIDA Sessions:
- Comorbid Psychiatric and Substance Use Disorders: Recent Research to Improved Diagnosis and Treatment
Saturday, May 14; 9:00 a.m. – 12:00 p.m.
Building B, Level 3, Room B312 - Marijuana: Assessing its Risks in a Changing Environment
Saturday, May 14; 2:00 p.m. – 5:00 p.m.
Building B, Level 3, Room B312 - Opioids: Crisis and Solutions
Sunday, May 15; 1:00 p.m. – 4:00 p.m.
Building B, Level 3, Room B312 - What Can Mental Health Providers Learn From Prevention and Management of Marijuana Use in Youth Pediatric Practices?
Sunday, May 15; 2:30 p.m. – 4:00 p.m.
Building B, Level 4, Room B406 - New Issues in Understanding Tobacco Use and Mental Illness
Monday, May 16; 9:00 a.m. – 12:00 p.m.
Building B, Level 4, Room B401 - Biologics (Vaccines, Monoclonal Antibodies and Enzymes) to Treat Drug Use Disorders and Overdose
Monday, May 16; 2:00 p.m. – 5:00 p.m.
Building B, Level 3, Room B312 - An Update on Diagnostic and Assessment Considerations for the Treatment of Comorbid Opioid Addiction and Chronic Pain
Monday, May 16; 2:00 p.m. – 5:00 p.m.
Building A, Level 4, Room A404/405 - Teen Misuse and Abuse of Prescription Drugs: Pathways to Drug Addiction
Tuesday, May 17; 2:00 p.m. – 5:00 p.m.
Building B, Level 3, Room B312
Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov
About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH. . .Turning Discovery Into Health®
